Quick Takeaways
- Matthew Angel filed SCHEDULE 13D for TEMPEST THERAPEUTICS, INC. Common Stock, par value $0.001 per share (TPST).
- Disclosed ownership: 36%.
- Date of event: 03 Feb 2026.
Matthew Angel - 03 Feb 2026 SCHEDULE 13D Report for TEMPEST THERAPEUTICS, INC. Common Stock, par value $0.001 per share (TPST)
- Filing Manager
- Matthew Angel
- Reporting Manager
- Matthew Angel
- Symbol
- TPST
- Shares outstanding
- 13,473,733 shares
- Disclosed Ownership
- 4,837,070 shares
- Ownership
- 36%
- Form type
- SCHEDULE 13D
- Filing time
- 10 Feb 2026, 17:15:28 UTC
- Date of event
- 03 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Matthew Angel disclosed 36% ownership in TEMPEST THERAPEUTICS, INC. Common Stock, par value $0.001 per share (TPST) on 03 Feb 2026."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 10 Feb 2026, 17:15.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Matthew Angel | 36% | 4,837,070 | 4,837,070 | 0 | /s/ Matthew Angel | Matthew Angel | 0001931356 |